Profiling and Case Study of Patients in a Diabetology Visit

Authors

  • Lúcia Meireles Brandão Serviço de Medicina 1; Unidade Local de Saúde do Alto Minho; Hospital de Santa Luzia; Viana do Castelo; Portugal
  • António Ferreira Serviço de Medicina 1; Unidade Local de Saúde do Alto Minho; Hospital de Santa Luzia; Viana do Castelo; Portugal
  • Cátia Barreiros Serviço de Medicina 1; Unidade Local de Saúde do Alto Minho; Hospital de Santa Luzia; Viana do Castelo; Portugal
  • Duarte Silva Serviço de Medicina 1; Unidade Local de Saúde do Alto Minho; Hospital de Santa Luzia; Viana do Castelo; Portugal
  • Joana Rodrigues Serviço de Medicina 1; Unidade Local de Saúde do Alto Minho; Hospital de Santa Luzia; Viana do Castelo; Portugal
  • Carmélia Rodrigues Serviço de Medicina 1; Unidade Local de Saúde do Alto Minho; Hospital de Santa Luzia; Viana do Castelo; Portugal
  • Cristina Roque Serviço de Medicina 1; Unidade Local de Saúde do Alto Minho; Hospital de Santa Luzia; Viana do Castelo; Portugal
  • Diana Guerra Serviço de Medicina 1; Unidade Local de Saúde do Alto Minho; Hospital de Santa Luzia; Viana do Castelo; Portugal

DOI:

https://doi.org/10.24950/rspmi/original/253/2/2018

Keywords:

Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, Diabetic Angiopathies, Dyslipidemias, Hypertension

Abstract

Background: Diabetes mellitus (DM) is one of the 21st century’s greatest challenges in health. The authors aimed to
characterize a group of patients with DM and to analyze their
vascular risk factors, metabolic profile, and the therapeutic
strategies used.
Material and Methods: In this retrospective observational
study, 300 patients with DM who had been followed in Diabetology visits for three years were randomly included. Data
were collected in the first and last visit in that period, using Sclínico®. Excel® and SPSS® were used for the statistical
analysis.
Results: The median age of the patients was 65 years, 61.7%
were male, and 83.3% had been diagnosed with type 2 DM.
During the analyzed period, the median hemoglobin A1C decreased from 8.2% to 7.2%, with a stable body-mass index,
and the antidiabetic therapy was intensified. Regarding the
remaining vascular risk factors, 72.7% of the patients had
arterial hypertension, 62.7% had dyslipidemia, 42.7% were
obese, 38.7% were sedentary, and 9.3% were smokers.
Moreover, 83% of the patients had LDL> 70 mg/dL. The most
common macrovascular complication was coronary heart
disease (14.0%), the most frequent microvascular complication was nephropathy (30.7%) and globally, the median
creatinine clearance was of 84.3 mL/min. The median global
cardiovascular risk was high (27.7%), even though 77.0% of
the patients were taking hypolipidemic drugs, 72.6% antihypertensive drugs, 41.3% anti-platelet aggregation drugs,
and 4.0% oral anticoagulation drugs.
Conclusion: The patient’s metabolic profile showed a favorable progression, with the intensification and adjustment of
antidiabetic therapies playing an important role.

Downloads

Download data is not yet available.

References

International Diabetes Federation IDF Diabetes Atlas 2015. 7th ed. Brussels: IDF; 2015.

Observatório Nacional da Diabetes. Diabetes: Factos e Números - O Ano de 2014 - Relatório Anual do Observatório Nacional da Diabetes 11/2015. Lisboa: Sociedade Portuguesa de Diabetologia; 2016.

Direção Geral da Saúde. Doenças Cérebro-Cardiovasculares em Números - 2015. Lisboa:DGS; 2016.

Satyajeet Roy. Atherosclerotic cardiovascular disease risk and evidence-based management of cholesterol. N Am J Med Sci. 2014; 6: 191- 8.

Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49-S73.

Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421-6.

Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med. 2011; 171: 404–10.

Holman RR, Sanjoy PK, Bethel MA, Matthews DR, Neil MA. UK Prospective Diabetes Study (UKPDS) Group; 10-Year Follow-up of intensive glucose control in Type 2 diabetes. N Engl J Med. 2008; 359: 1577– 89.

Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol. 2009;53(5 Suppl):S35-42.

S. Zoungas, J. Chalmers, B. Neal, L. Billot, Q. Li, Y. Hirakawa, et al, for the ADVANCE-ON Collaborative Group. Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes, N Engl J Med. 2014;371:1392-406.

de Vries FM, Denig P, Pouwels KB, Postma MJ, Hak E. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis. Drugs. 2012;72:2365-73.

Querton L, Buysschaert M, Hermans MP. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels. J Clin Lipidol. 2012;6:434-42

Davide Capodanno and Dominick J. Angiolillo, Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus; Circulation. 2016;134:1579-94

Cardiovascular Disease and Risk Management, American Diabetes Association, Diabetes Care. 2016; 39(Suppl 1): S60-S71.

Published

2018-06-13

How to Cite

1.
Meireles Brandão L, Ferreira A, Barreiros C, Silva D, Rodrigues J, Rodrigues C, Roque C, Guerra D. Profiling and Case Study of Patients in a Diabetology Visit. RPMI [Internet]. 2018 Jun. 13 [cited 2024 Dec. 18];25(2):100-6. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/449

Issue

Section

Original Articles

Most read articles by the same author(s)